Novartis (NVS) PT Lowered to $94 at Bernstein
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/16/2026
- S&P 500 ends higher as traders shift from AI to healthcare
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent steady as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
Tweet
Share
E-mail
Get Alerts NVS Hot Sheet
Price: $150.38 --0%
Rating Summary:
7 Buy, 15 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 14 | New: 36
Rating Summary:
7 Buy, 15 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 14 | New: 36
Join SI Premium – FREE
Bernstein lowered its price target on Novartis (NYSE: NVS) to $94.00 (from $103.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EssilorLuxottica SA (EL:FP) (ESLOY) PT Lowered to EUR180 at Morgan Stanley
- First Watch (FWRG) PT Lowered to $18 at Raymond James
- Holmen AB (HOLMB:SS) PT Lowered to SEK299 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Sanford C. BernsteinSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
